Janus Henderson Group’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-6,103,797
| Closed | -$144M | – | 2592 |
|
|
2023
Q4 | $144M | Sell |
6,103,797
-699,687
| -10% | -$16.5M | 0.09% | 214 |
|
|
2023
Q3 | $101M | Sell |
6,803,484
-943,103
| -12% | -$14.1M | 0.07% | 243 |
|
|
2023
Q2 | $84.8M | Buy |
7,746,587
+250,538
| +3% | +$2.74M | 0.05% | 283 |
|
|
2023
Q1 | $65.4M | Buy |
7,496,049
+6,252,380
| +503% | +$54.5M | 0.04% | 323 |
|
|
2022
Q4 | $7.79M | Buy |
+1,243,669
| New | +$7.79M | 0.01% | 773 |
|